Patents matching “alcohol”

US 20260125398

5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS

AMGEN INC [US] · Granted May 7, 2026 · Expires May 2, 2046

US 12161621

Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease

The Regents of the University of Colorado · Granted Dec 10, 2024 · Expires Dec 5, 2044

US 11896603

Oligosaccharide as therapeutic agent for alcohol associated liver disease

The Regents of the University of California · Granted Feb 13, 2024 · Expires Feb 8, 2044

US 11547736

Sauvignon blanc grape seed products for nonalcoholic fatty liver disease

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11528924

Alcoholic beverage substitutes

CLEARMIND MEDICINE INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

US 11484523

Compositions for prevention and treatment of symptoms associated with alcohol consumption

Purple Biosciences LLC · Granted Nov 1, 2022 · Expires Oct 27, 2042

US 11439635

B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease

Northwestern University · Granted Sep 13, 2022 · Expires Sep 8, 2042

US 11400072

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11400052

Alcohol-resistant drug formulations

Jazz Pharmaceuticals Ireland Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11357777

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

Cyclerion Therapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

US 11298317

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuteria Beverages, LLC · Granted Apr 12, 2022 · Expires Apr 7, 2042

US 11179384

Treatment of nonalcoholic fatty liver disease

TAKEDA GMBH · Granted Nov 23, 2021 · Expires Nov 18, 2041

US 11135309

Poly(vinyl alcohol) nanocarriers

The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

US 10941248

Methods for preparing functionalized polymers from polymer alcohols

Nektar Therapeutics · Granted Mar 9, 2021 · Expires Mar 4, 2041

US 10894073

Pinot noir grape products for nonalcoholic fatty liver disease and other uses

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 19, 2021 · Expires Jan 14, 2041

US 10772865

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

US 10731116

Alcoholic compositions having a lowered risk of acetaldehydemia

Deuteria Beverages, LLC · Granted Aug 4, 2020 · Expires Jul 30, 2040

US 10555929

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

US 10537528

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds

The Regents of the University of California · Granted Jan 21, 2020 · Expires Jan 16, 2040

US 10357460

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS · Granted Jul 23, 2019 · Expires Jul 18, 2039

US 10307386

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

US 10258576

Particulate comprising a calcium-containing compound and a sugar alcohol

TAKEDA AS · Granted Apr 16, 2019 · Expires Apr 11, 2039

US 10144804

Method for preparing functionalized polymers from polymer alcohols

Nektar Therapeutics · Granted Dec 4, 2018 · Expires Nov 29, 2038

US 10130671

Chardonnay grape seed products for nonalcoholic fatty liver disease

The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2018 · Expires Nov 15, 2038